Hiromi Nakano
Research Subjects
Hiromi Nakano has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Kazuo Shigematsu
Department of Neurology, Nagitsuji hospital
3 shared publications - Yoshiyuki Watanabe
Kyoto Prefectural University of Medicine Graduate School of Medical Science
2 shared publications - Akihiko Nishizawa
Department of Internal Medicine, The Nishizawa Clinic, Kyoto, Japan
1 shared publication - Atsushi Okumura
Department of Neurosurgery, Jujyo Rehabilitation Hospital, Kyoto, Japan
1 shared publication - Kouichiro Shimizu
Department of Neurosurgery, Kyoto Fushimi Shimizu Hospital, Kyoto, Japan
1 shared publication - Masahiro Makino
Department of Neurology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan
1 shared publication
Latest Publications
- Open Access
Smoking Habits and the Onset of Stroke: Insights from the Kyoto Stroke Registry
Cigarette smoking is a well-established risk factor for stroke due to its contribution to atherosclerosis. This study utilized data from the Kyoto Stroke Registry (KSR) spanning April 1997 to March 2020 to investigate the relationship between smoking history and the age at which stroke occurs. The study focused on stroke patients registered in the KSR, categorizing them into four groups based on their smoking history: those with no smoking history, individuals who quit smoking more than one year ago, those who smoked fewer than 20 cigarettes per day, and those who smoked more than 20 cigarettes per day. The primary objective was to compare the age at which stroke onset occurred among these groups, employing statistical analysis through a Student t-test to identify significant differences. After excluding patients with missing smoking status information, the analysis involved 30,491 stroke patients. The results revealed a noteworthy association: individuals with a smoking history, particularly heavy smokers, experienced a significantly younger age at stroke onset compared to those who had never smoked. Moreover, the study found that quitting smoking for more than one year was linked to a later onset of stroke compared to continuing to smoke. This observation held true even among those who smoked less than 20 cigarettes per day. Furthermore, the study’s findings remained consistent across all stroke types, including cerebral infarction, cerebral hemorrhage, and subarachnoid hemorrhage, regardless of gender. In conclusion, this comprehensive analysis of the KSR data reinforces the well-established notion that smoking history plays a critical role in the timing of stroke onset. Importantly, it underscores the potential benefits of smoking cessation, as well as the avoidance of smoking altogether, in reducing the risk of stroke. These findings carry significant implications for public health initiatives aimed at stroke prevention and emphasize the pivotal role of smoking cessation programs in mitigating the risk of stroke-associated morbidity and mortality.
Open AccessSmoking Habits and the Onset of Stroke: Insights from the Kyoto Stroke Registry
Cigarette smoking is a well-established risk factor for stroke due to its contribution to atherosclerosis. This study utilized data from the Kyoto Stroke Registry (KSR) spanning April 1997 to March 2020 to investigate the relationship between smoking history and the age at which stroke occurs. The study focused on stroke patients registered in the KSR, categorizing them into four groups based on their smoking history: those with no smoking history, individuals who quit smoking more than one year ago, those who smoked fewer than 20 cigarettes per day, and those who smoked more than 20 cigarettes per day. The primary objective was to compare the age at which stroke onset occurred among these groups, employing statistical analysis through a Student t-test to identify significant differences. After excluding patients with missing smoking status information, the analysis involved 30,491 stroke patients. The results revealed a noteworthy association: individuals with a smoking history, particularly heavy smokers, experienced a significantly younger age at stroke onset compared to those who had never smoked. Moreover, the study found that quitting smoking for more than one year was linked to a later onset of stroke compared to continuing to smoke. This observation held true even among those who smoked less than 20 cigarettes per day. Furthermore, the study’s findings remained consistent across all stroke types, including cerebral infarction, cerebral hemorrhage, and subarachnoid hemorrhage, regardless of gender. In conclusion, this comprehensive analysis of the KSR data reinforces the well-established notion that smoking history plays a critical role in the timing of stroke onset. Importantly, it underscores the potential benefits of smoking cessation, as well as the avoidance of smoking altogether, in reducing the risk of stroke. These findings carry significant implications for public health initiatives aimed at stroke prevention and emphasize the pivotal role of smoking cessation programs in mitigating the risk of stroke-associated morbidity and mortality.
- Open Access
- 25 March 2015
- Published by Springer Nature in BMC Neurology
- Vol. 15 (1) , 44
Influences of hyperlipidemia history on stroke outcome; a retrospective cohort study based on the Kyoto Stroke Registry
Although hyperlipidemia is known as a risk factor of stroke, its effects on the outcome are unknown. The aim of the study is to clarify the influences of hyperlipidemia on the stroke early outcome by estimating odds ratio (OR) for sequelae requiring care and hazard ratio (HR) for death. A total of 12617 stroke patients registered in the Kyoto Stroke Registry with information on a hyperlipidemia history. We compared patients who had hyperlipidemia history and patients who hadn’t. The OR for remaining sequelae requiring certain care on 30 day after stroke was calculated using a logistic regression in stroke as a whole and in each stroke subtype; cerebral infarction (CI), cerebral hemorrhage (CH) and subarachnoid hemorrhage (SAH). The HR for death within 30 day after stroke was estimated by the Cox regression. The OR (95% confidence interval) for remaining sequelae 30 days after stroke was 0.66 (0.60-0.73, p < 0.001) in patients with hyperlipidemia history compared with patients without hyperlipidemia history. After stratified by stroke subtypes, it was 0.75 (0.67-0.85, p < 0.001) in CI, 0.59 (0.45-0.77, p < 0.001) in CH and 0.77 (0.43-1.38, p = 0.767) in SAH. The HR (95% confidence interval) for death was 0.39 (0.31-0.48, p < 0.001) in patients with hyperlipidemia history comparing patients without hyperlipidemia history. After stratified by stroke subtypes, it was 0.45 (0.32-0.63, p < 0.001) in CI, 0.64 (0.44-0.93, p = 0.018) in CH and 0.76 (0.47-1.23, p = 0.264) in SAH. Each value was adjusted for age and sex. This study suggests that the outcome is favorable for patients with hyperlipidemia history in terms of both remaining sequelae and HR for death. A factor which increases the incidence of the disease could influence on the severity of the disease in a favorable way.
- 25 March 2015
- Published by Springer Nature in BMC Neurology
- Vol. 15 (1) , 44
Open AccessInfluences of hyperlipidemia history on stroke outcome; a retrospective cohort study based on the Kyoto Stroke Registry
Although hyperlipidemia is known as a risk factor of stroke, its effects on the outcome are unknown. The aim of the study is to clarify the influences of hyperlipidemia on the stroke early outcome by estimating odds ratio (OR) for sequelae requiring care and hazard ratio (HR) for death. A total of 12617 stroke patients registered in the Kyoto Stroke Registry with information on a hyperlipidemia history. We compared patients who had hyperlipidemia history and patients who hadn’t. The OR for remaining sequelae requiring certain care on 30 day after stroke was calculated using a logistic regression in stroke as a whole and in each stroke subtype; cerebral infarction (CI), cerebral hemorrhage (CH) and subarachnoid hemorrhage (SAH). The HR for death within 30 day after stroke was estimated by the Cox regression. The OR (95% confidence interval) for remaining sequelae 30 days after stroke was 0.66 (0.60-0.73, p < 0.001) in patients with hyperlipidemia history compared with patients without hyperlipidemia history. After stratified by stroke subtypes, it was 0.75 (0.67-0.85, p < 0.001) in CI, 0.59 (0.45-0.77, p < 0.001) in CH and 0.77 (0.43-1.38, p = 0.767) in SAH. The HR (95% confidence interval) for death was 0.39 (0.31-0.48, p < 0.001) in patients with hyperlipidemia history comparing patients without hyperlipidemia history. After stratified by stroke subtypes, it was 0.45 (0.32-0.63, p < 0.001) in CI, 0.64 (0.44-0.93, p = 0.018) in CH and 0.76 (0.47-1.23, p = 0.264) in SAH. Each value was adjusted for age and sex. This study suggests that the outcome is favorable for patients with hyperlipidemia history in terms of both remaining sequelae and HR for death. A factor which increases the incidence of the disease could influence on the severity of the disease in a favorable way.
- Open Access
- 15 July 2013
- Published by Springer Nature in BMC Neurology
- Vol. 13 (1) , 87
Speech disturbance at stroke onset is correlated with stroke early mortality
Speech disturbance is a common symptom of stroke and is important as a prompt identifier of the event. The frequency of the symptom among each stroke subtype, differences between patients with and without speech disturbance and its correlation to early mortality remain unclear. The Kyoto prefecture of Japan has established a registry to enroll new stroke patients in cooperation with the Kyoto Medical Association and its affiliated hospitals. It is named the Kyoto Stroke Registry (KSR). We confirmed the existence or absence of speech disturbance in 1693 stroke patients registered to the KSR and investigated associations between speech disturbance and other characteristics. Speech disturbance was observed in 52.6% of cerebral infarction (CI), 47.5% of cerebral hemorrhage (CH), and 8.0% of subarachnoid hemorrhage (SAH) cases. Characteristics showing statistically significant differences between patients with and without speech disturbance and patients were age, blood pressure, history of hypertension, arrhythmia and diabetes mellitus, habit of tobacco and alcohol, and paresis. Mortality rates of patients with/without speech disturbance were 5.2%/1.2% for CI, 12.5% /4.1% for CH, and 62.5%/ 9.0% for SAH. Adjusted hazard ratios were 2.63 (1.14-6.13, p = 0.024) in CI, 4.15 (1.41-12.23, p = 0.010) in CH, and 20.46 (4.40-95.07, p < 0.001) in SAH). Speech disturbance was frequently observed in stroke patients at the onset and therefore could be useful to identify the problem at the earliest stage. Hazard ratio for death was higher in stroke patients with speech disturbance than patients without. Speech disturbance is a prompt predictor of stroke early mortality. Hiromi Nakano, Yoshiyuki Watanabe, Tatsuyuki Sekimoto, Kouichiro Shimizu, Akihiko Nishizawa, Atsushi Okumura and Masahiro Makino contributed equally to this work.
- 15 July 2013
- Published by Springer Nature in BMC Neurology
- Vol. 13 (1) , 87
Open AccessSpeech disturbance at stroke onset is correlated with stroke early mortality
Speech disturbance is a common symptom of stroke and is important as a prompt identifier of the event. The frequency of the symptom among each stroke subtype, differences between patients with and without speech disturbance and its correlation to early mortality remain unclear. The Kyoto prefecture of Japan has established a registry to enroll new stroke patients in cooperation with the Kyoto Medical Association and its affiliated hospitals. It is named the Kyoto Stroke Registry (KSR). We confirmed the existence or absence of speech disturbance in 1693 stroke patients registered to the KSR and investigated associations between speech disturbance and other characteristics. Speech disturbance was observed in 52.6% of cerebral infarction (CI), 47.5% of cerebral hemorrhage (CH), and 8.0% of subarachnoid hemorrhage (SAH) cases. Characteristics showing statistically significant differences between patients with and without speech disturbance and patients were age, blood pressure, history of hypertension, arrhythmia and diabetes mellitus, habit of tobacco and alcohol, and paresis. Mortality rates of patients with/without speech disturbance were 5.2%/1.2% for CI, 12.5% /4.1% for CH, and 62.5%/ 9.0% for SAH. Adjusted hazard ratios were 2.63 (1.14-6.13, p = 0.024) in CI, 4.15 (1.41-12.23, p = 0.010) in CH, and 20.46 (4.40-95.07, p < 0.001) in SAH). Speech disturbance was frequently observed in stroke patients at the onset and therefore could be useful to identify the problem at the earliest stage. Hazard ratio for death was higher in stroke patients with speech disturbance than patients without. Speech disturbance is a prompt predictor of stroke early mortality. Hiromi Nakano, Yoshiyuki Watanabe, Tatsuyuki Sekimoto, Kouichiro Shimizu, Akihiko Nishizawa, Atsushi Okumura and Masahiro Makino contributed equally to this work.